Inauguration of Mitsubishi Chemical Holdings Corporation.TOKYO -- Mitsubishi Chemical Corporation Mitsubishi Chemical Corporation (三菱化学株式会社 ("MCC (The Microelectronics and Computer Technology Corporation, Austin, TX) The first high-tech research and development consortium in the U.S., created in 1982 by leading companies within the electronics industry. ") (Head office: Minato-ku, Tokyo; President: Ryuichi Tomizawa), and Mitsubishi Pharma Mitsubishi Pharma Corporation (三菱ウェルファーマ株式会社 Corporation ("MPC (1) (Mobile PC) A handheld or laptop computer. See handheld computer, laptop computer and Ultra-Mobile PC. (2) (MultiPath Channel) See multipath. ") (Head office: Chuo-ku, Osaka Osaka (ō`säkä), city (1990 pop. 2,623,801), capital of Osaka prefecture, S Honshu, Japan, on Osaka Bay, at the mouth of the Yodo River. ; President: Takeshi Takeshi (which might be written in several ways, such as 武, 毅, 猛, or 健史, katakana:タケシ; hiragana: たけし) is a Japanese given name. Komine) jointly have established a holding company, Mitsubishi Chemical Holdings Mitsubishi Chemical Holdings Corporation (株式会社三菱ケミカルホールディングス Corporation ("MCHC MCHC mean corpuscular hemoglobin concentration. MCHC abbr. mean cell hemoglobin concentration Mean corpuscular hemoglobin concentration (MCHC) ") on October October: see month. 3, 2005, by a stock-for-stock exchange. With the establishment of MCHC, MCC and MPC have become the wholly owned subsidiaries Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of MCHC, and both have started the operations as core business companies of the MCHC Group today. The MCHC Group consists of MCC and MPC including both Group companies. As the holding company, MCHC will further develop and enhance its Group portfolio management, to increase the Group value and accelerate strengthening of the pharmaceutical business, as well as expedite ex·pe·dite tr.v. ex·pe·dit·ed, ex·pe·dit·ing, ex·pe·dites 1. To speed up the progress of; accelerate. 2. business restructuring restructuring - The transformation from one representation form to another at the same relative abstraction level, while preserving the subject system's external behaviour (functionality and semantics). and alliances.
Profile of MCHC
1) Company name: Mitsubishi Chemical Holdings
Corporation
2) Group name: Mitsubishi Chemical Holdings Group
3) Incorporation date: October 3, 2005
4) Head office: 33-8 Shiba 5-chome, Minato-ku, Tokyo
108-0014
5) President: Ryuichi Tomizawa
6) Capital: 50 billion yen
7) Outstanding shares a) Type of shares: Common share
b) Number of shares: 1,806,288,107
c) Unit shares: 500
8) Fiscal year end: March 31
9) Listings: Tokyo Stock Exchange
Osaka Securities Exchange
(Securities code: 4188)
10) Directors and Officers Please see Reference 1.
11) Organization: Please see Reference 2.
12) Expected net sales: 2,380 billion yen
(Consolidated)
13) Group companies: About 370
14) Employees: a) MCHC: 62*
*All employees are on loan from MCC
and MPC.
b) MCHC Group: 33,261
Reference 1
List of Directors and Officers
As of October 3, 2005
Representative Director, Ryuichi Tomizawa
Member of the Board,
President
----------------------------- ------------------- --------------------
Representative Director, Yosuke Yamada Chief Compliance
Member of the Board, Officer
Senior Managing Executive Presidential
Officer Assistant
Supervising -
Administration,
Human Resources,
Public Relations,
CSR, and Internal
Audit
----------------------------- ------------------- --------------------
Representative Director, Takeshi Komine
Member of the Board
----------------------------- ------------------- --------------------
Member of the Board, Ryuichi Sato Supervising -
Managing Executive Officer Corporate Strategy
----------------------------- ------------------- --------------------
Member of the Board, Hisashi Ishikawa Supervising -
Managing Executive Officer Corporate
Management, Investor
Relations
----------------------------- ------------------- --------------------
Member of the Board Masaoki Funada
----------------------------- ------------------- --------------------
Member of the Board Yoshiyuki Maekawa
----------------------------- ------------------- --------------------
Member of the Board Kunihiko Shimojuku
----------------------------- ------------------- --------------------
Managing Executive Officer Kiyoshi Nakayama Supervising - Health
Care Strategy
----------------------------- ------------------- --------------------
Executive Officer Kenichi Uno General Manager,
Corporate Strategy
Office
----------------------------- ------------------- --------------------
Executive Officer Noboru Tsuda General Manager,
Internal Audit
Office
----------------------------- ------------------- --------------------
Executive Officer Shigeyoshi Murase Deputy General
Manager, Corporate
Management Office
----------------------------- ------------------- --------------------
Executive Officer Shotaro Yoshimura General Manager,
Corporate
Management Office
----------------------------- ------------------- --------------------
Corporate Auditor (full-time) Hideaki Yoshida
----------------------------- ------------------- --------------------
Corporate Auditor (full-time) Yoshikazu Takagaki*
----------------------------- ------------------- --------------------
Corporate Auditor Takayasu Kishi
----------------------------- ------------------- --------------------
Corporate Auditor Hiroyasu Sugihara*
----------------------------- ------------------- --------------------
Corporate Auditor Somitsu Takehara*
----------------------------- ------------------- --------------------
*Outside Corporate Auditor
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion